MedPath
FDA Approval

Cytra-K Crystals

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 20, 2016
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Potassium citrate(3.3 g in 1 1)
VS-01(1.002 g in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Cypress Pharmaceutical, Inc.

790248942

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Tower Laboratories Ltd

Cypress Pharmaceutical, Inc.

Cypress Pharmaceutical, Inc.

001587203

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cytra-K Crystals

Product Details

NDC Product Code
60258-005
Route of Administration
ORAL
Effective Date
September 20, 2016
Saccharin Sodium AnhydrousInactive
Code: I4807BK602Class: IACTQuantity: 33 mg in 1 1
Code: EE90ONI6FFClass: ACTIBQuantity: 3.3 g in 1 1
VS-01Active
Code: 2968PHW8QPClass: ACTIMQuantity: 1.002 g in 1 1
© Copyright 2025. All Rights Reserved by MedPath